Bruce D. Levy, MD 

Dr. Levy is the Parker B. Francis Professor of Medicine at Brigham and Women’s Hospital and the Division Chief of the Pulmonary and Critical Care Division. Bruce received his MD from the University of Pennsylvania School of Medicine. He completed his internship and residency in Internal Medicine and his fellowship in Pulmonary and Critical Care at Brigham and Women’s Hospital. He was a post-doctoral fellow in the laboratory of Dr. Charles Serhan.  Research undertaken in the Levy laboratory focuses on the roles of endogenous counter-regulatory mediators in the lung. The lab’s mission is “to identify novel pathways and cellular targets that promote resolution of pulmonary inflammation or injury and to determine roles for naturally-derived, specialized pro-resolving mediators in lung health and disease as well as their potential as templates for rational new drug design.” A list of Dr. Levy’s publications can be found on Pubmed.


Raja-Elie Abdulnour, MD

Raja received his MD from the American University of Beirut, Lebanon. After a post-doctorate fellowship at the Johns Hopkins School of Medicine, he completed his Internal Medicine residency at the Johns Hopkins Hospital in Baltimore, and his Pulmonary and Critical Care Medicine fellowship at the Harvard combined program. He completed a post-doctorate fellowship in the Levy lab, and is now an assistant professor of Medicine at the Harvard Medical School. In addition to clinical responsibilities at the Brigham and Women’s Hospital Medical Intensive Care Unit and the Dana-Farber Cancer Institute, Raja remains a member of the Levy lab and continues to investigate the impact of specialized pro-resolving lipid mediators on acute lung inflammation and infection. A list of Raja’s publications can be found on Pubmed. Email:

Christianah Tolulope Ademuwagun

Christianah received her BS in Biology from Howard University. She joined the Levy Lab in September 2019 as a research technician after completing a Master of Science in Biology Medical Sciences. She is currently working with Elaine Cagnina to investigate host immune response to Aspergillus fumigatus lung infection in a mouse model. Christianah plans to attend medical school in the near future.


Thayse Regina Bruggemann, PhD

Thayse received her PhD in Medical Sciences from School of Medicine of Sao Paulo University – Brazil (June 2017). In June 2017 she joined Levy Lab for a postdoctoral fellowship. Her interest is to extend the knowledge about the connection of the immune system with the specialized pro-resolving mediators pathways in different lung diseases subsets. She is currently working on the in vivo and in vitro roles and mechanisms for phospholipid phosphatase 6 regulation of specific cell functions on macrophages and dendritic cells. A list of Thayse’s publications can be found on Pubmed. Email:

Rebecca Elaine Cagnina, MD, PhD

Elaine received her MD and PhD degrees in 2010 as part of the Medical Scientist Training Program at the University of Virginia.   She subsequently completed residency in Internal Medicine and a fellowship in Pulmonary and Critical Care Medicine at the University of Virginia before joining their faculty in 2016.  She moved to BWH and joined the Levy Lab in 2018.  Her current research investigates the host immune response in a mouse model of Aspergillus lung injury.  More broadly, she is interested in how innate immune cells influence the development of effective adaptive immunity in the context of pulmonary infections with the goal of applying new insights to the development of novel therapies. Email:

Lauren Frazer, MD PhD

Lauren received her MD and PhD in 2014 from the University of Pittsburgh as a member of the Medical Scientist Training Program.  Her research focused on the immunobiology of Chlamydia infection. She then completed a pediatrics residency at the University of North Carolina at Chapel Hill in 2018. She is currently a fellow in newborn medicine at Boston Children’s Hospital and joined the Levy lab in 2019.  Lauren is interested in neonatal immunology and the resolution of innate inflammation in the lungs of premature infants with a focus on specialize pro-resolving mediators. Her long-term goal is to contribute to the development of novel therapies for neonatal lung disease. Email:

Melody Duvall, MD, PhD

Melody received her PhD in Immunology from Oxford University, United Kingdom, in 2006 through the NIH-Oxford Graduate Partnership Program and her MD from Washington University in St. Louis School of Medicine in 2008. She completed her pediatrics residency at Boston Children’s Hospital in 2012 and her pediatric critical care medicine fellowship at Boston Children’s Hospital in 2015. She joined the Levy lab in 2014. Melody is investigating the phenotype and function of innate mediators of immunity (in particular innate lymphoid cells (ILCs), natural killer (NK) cells, and mucosal associated invariant T (MAIT) cells in human children with viral lung infection and respiratory failure.  A list of Melody’s publications can be found on Pubmed. Email:

Bakr Jundi, MD MMSc

Bakr received his MD from the Royal College of Surgeons in Ireland in 2017. During his time in medical school, he worked on a number of different research projects involving the role of neutrophils in Cystic Fibrosis and Alpha-1 Antitrypsin Deficiency. He recently graduated with a Masters degree in Clinical Investigation (MMSCI) at the Harvard Medical School. Bakr’s research focus in the Levy lab will be assessing the function of neutrophils in sepsis using microliter quantities of human blood. He plans on continuing this research before entering residency in the US. Email:

Ayşe Kılıҫ, PhD

Ayşe obtained her PhD in immunology at the Philipps-University Marburg in Germany, with a focus on neuro-immune mechanisms in promoting allergic airway inflammation and remodeling processes in the lung. Since her post-doctoral work she is applying systems biology approaches to immunology, aiming to decipher molecular mechanisms in CD4+ T helper subsets in initiating and sustaining allergic inflammation. To further advance her skills in multi-omics data analysis and integration, she joined the Channing Division of Network Medicine at BWH (PI: Dr. Scott Weiss) in 2017. In a collaborative project with the Levy lab, she is investigating the impact of Vitamin D on the development of allergic diseases. Email:

Nandini Krishnamoorthy, PhD

The overarching theme of Nandini’s research has been the identification of pathways that bridge innate and adaptive immune systems. During her PhD and postdoctoral work, she has been involved in studies that explore this connection along multiple dimensions. She is particularly interested in understanding mechanisms behind regulatory T cells dysfunctional during chronic inflammation. She is currently dissecting the cellular interactions between innate lymphoid cells and regulatory T cells in the setting of Respiratory Syncytial Virus (RSV). A complete list of Nandini’s publications can be found at Pubmed. Email:

Roisin (Rosie) Reilly

Roisin Reilly joined the Levy Lab as a research assistant in July 2019, after spending the previous two summers in the lab as an undergraduate research trainee. She graduated from Boston College with a major in English literature and a minor in chemistry. In the lab, she works with Melody Duvall to study the effects of specialized pro-resolving mediators (SPMs) on natural killer (NK) cell phenotype and cytotoxic function. She hopes to attend medical school in the future. Email:

Luciana Tavares, PhD

Luciana received her PhD in Immunology from Universidade Federal de Minas Gerais – Brazil in 2018. She joined Dr. Bruce Levy’s lab in 2017, where she did part of her PhD project. Now she is a post-doctoral fellow in the Levy’s lab. Her main interest is to understand the role of inflammation and resolution during lung infections, especially influenza and pneumococcal coinfections.  


Hong Yong Peh, PhD

Hong Yong received his PhD in Medicine, majoring in immuno-pharmacology from National University of Singapore (NUS) in 2017. He was awarded the NUS-Overseas Postdoctoral Fellowship at graduation, where he was co-appointed as Senior Tutor in the Department of Pharmacology at Yong Loo Lin School of Medicine, and Postdoctoral Research Fellow at Harvard Medical School, USA. He joined the Levy lab in 2017. His current research projects include allergen and inflammatory mediators induced lung and skin injury, the mechanisms of resolution biology, and the efficacy of specialized pro-resolving mediators in promoting resolution in various tissue injury. A list of Hong Yong’s publications can be found on Pubmed. Email:

Katherine H. Walker, MD MSc

Kate received her MD from Harvard Medical School in 2011, after completing a Masters of Science in Medical Anthropology at Oxford University.  She completed residency training in Internal Medicine at Brigham and Women’s Hospital in 2014, and subsequently joined the Division of Pulmonary and Critical Care for fellowship training, joining the Levy Lab in 2015.  Her research interests include viral-mediated lung injury and inflammation, and the potential impact of specialized pro-resolving lipid mediators in that setting. Email:

Guangli Zhu, MD

Guangli is a senior technician in the Levy Lab. Gualngli received her M.D. from China where she trained in anesthesiology and surgery. She has been working in Dr. Levy’s lab since 2006 on the murine model of asthma and acute lung injury. Guangli is responsible for maintaining lab supply inventory as well as ordering supplies, equipment and reagents for the lab. Email:

Ajantha Nadesalingam, Student, Ontario Science Centre School, Toronto, Canada

Alexandre de Paula Rogerio, Associate Professor, Federal University of Triângulo Mineiro, Sao Paolo, Brazil

Alexander H. Tavares, Graduate School, Boston University, Boston, USA

Anna Planaguma, Research Scientist, Almirall Pharmaceuticals, Barcelona, Spain

Braden D. Engstrom, Medical Student, University of Michigan, Ann Arbor, Michigan

Caroline Bonnans, Researcher, INSERM, Montpelier, France

Cindy Barnig, Assistant Professor, Departement de Pathologie Thoracique – Nouvel Hopital Civil Strasbourg, France

Cindy Hana Okuma, Postdoctoral Research Fellow, – University of Sao Paulo, Sao Paulo, Brazil

David Douda, Research Scientist, Therapeutics R&D, Zymeworks Inc.

Emiko Ono, Postdoctoral scholar, Weill-Cornell Medicine, New York, NY

Fiona A Ringholz, Consultant, Our Lady’s Children Hospital, Dublin, Ireland

Francesca Levi-Schaffer, Professor, The Hebrew University of Jerusalem, Dept. of Pharmacology, Jerusalem, Israel

Frantz Hastrup, Intensivist, Overlake Medical Center, Seattle, WA

Geoffrey Rubin, Internal Medicine Resident, Columbia University College of Physicians & Surgeons, New York, NY

Hiroyuki Seki, Assistant Professor, Keio University, Anesthesiologist, Saiseikai-Chuo Hospital, Tokyo, Japan

Ho Pan (Andy) Sham, Research Scientist, Qu Biologics

Ingibjorg Haroardottier, Professor in Biochemistry and Molecular Biology Biomedical Center, Faculty of Medicine, University of Iceland, Reykjavik

Isabell Baumann, Resident Physician, University of Hamburg

Jack Timmons, Doctor of Pharmacy, UCSF

Jan Hilberath, Deputy Head, ICU, University of Tubingen, Tubingen, Germany

Jennifer Colby, Assistant Professor, University of Texas, MD Anderson Cancer Center

Joanna Barkas, Medical Student, Tufts University

Koichi Fukunaga, Assistant Professor, Keio University, Tokyo, Japan

Laila Karra, Post-doctorate scholar, The Hebrew University of Jerusalem, Dept. of Pharmacology, Jerusalem, Israel

Laura Basu, Master’s Degree – Pharmacy, University of Uppsala, Uppsala, Sweden

Mary Fuhlbrigge, Medical School, University of Colorado, USA

Michael Pfeffer, Medical School, University of Queensland / Ochsner Health System, New Orleans, LA

Mohib Uddin, Research Scientist, Astra-Zeneca, Stockholm, Sweden

Olaf Eickmeier, Instructor, Goethe University, Frankfurt, Germany

Oliver Haworth, Researcher, William Harvey Research Institute, London, England

Payal Kohli, Cardiology Fellow, University of California San Francisco, San Francisco, CA

Rebekah Priluck, Medical Student, University of Nebraska School of Medicine, Omaha, NE

Roxanne Croze, Post-doctorate scholar, UCSF, San Francisco

Troy Carlo, Senior Research Scientist, CRISPR Therapeutics, Cambridge MA